B Riley Recent News
Urban Outfitters' Record Q2: The Sell-Side's Take
B Riley Likes Tocagen On Prospects For Company's Brain Cancer Drug
Analyst Takes Carvana For A Spin, Double Upgrades On Solid Float, Long-Term Opportunity
With Alnylam Pharma Down More Than 15%, Analyst Says Buy The Dip
Lululemon's Q4 Has The Sell Side Saying 'Namaste'
Nike's Innovation Pipeline Fuels Analyst Optimism Ahead Of Q3 Report, Despite Management Shake-Up
Priority Review For Tetraphase's Eravacycline A 'Key Positive,' Analyst Says
Guess Provides 'Excellent Opportunity' To Try On A Turnaround Story, Says B Riley FBR
Deciphera Pharma Scores A Sell-Side Recommendation
Salesforce Partners With Google: Everything You Should Know
Plot Twist: AMC Entertainment's Messy Q3 Carries Positive Themes
Not All Footwear Stores Are Struggling: DSW Steps Into A Buy Rating After Q2 Beat
On Western Digital's Updated Guidance, B. Riley Still Prefer Marvell
B. Riley Positive On Immersion Ruling Against Apple
The Acquisition Of Starz Should Help Lions Gate Diversify
B. Riley Upgrades SanDisk To Buy Following Q2 Results
Voxx Boosted To Buy At B Riley, 'Growth Seems Inevitable'
Analysts Aren't Sure Why Groupon Stock Is Down
B Riley Downgrades Semtech To Sell
B Riley Initiates Crocs With Neutral
What's Coming For Best Buy?
B Riley Upgrades Stage Stores To Buy
2 B. Riley Analysts Just Commented On These 3 Retailers